Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ascending, broader, concentration, Consumer, copy, counsel, dangerously, director, evolving, methodology, pharmacology, release, SIRM, SOX, specialist, wholly
Removed:
annually, bacteria, BCE, Canadian, certolizumab, children, CIMZIA, CMS, Crohn, degeneration, diminish, edema, expired, family, foregoing, gene, HITECH, immunoglobulin, imposed, injection, investigate, invoice, macular, neovascular, Occulsion, pegol, prevalence, promoter, pursued, ranibizumab, ready, recommendation, Retinopathy, rheumatoid, secretion, submission, teaching, trend, UCB, unavailability, Vein, wet, withdrawing
Filing tables
Filing exhibits
XOMA similar filings
Filing view
External links